2014
DOI: 10.13181/mji.v23i1.691
|View full text |Cite
|
Sign up to set email alerts
|

Challenges on management of heart failure in Indonesia: a general practitioner’s perspective

Abstract: Heart failure has become a public health problem with increasing incidence and prevalence. Many patients first came to the primary care and managed by general practitioner. Accurate diagnosis is essential to provide good management of heart failure. However, symptoms and signs alone are often neither sufficient nor specific to confirm the diagnosis. Some studies show that heart failure patients are still incorrectly diagnosed and inadequately treated, despite the availability of current guidelines. Inadequacy … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 19 publications
(38 reference statements)
0
2
0
Order By: Relevance
“…In their report, Siswanto, et al found that patients hospitalized for HF in Indonesia tend to have severe symptoms and lower LVEF [ 22 ]. It is a challenge for primary care providers and general practitioners in Indonesia to improve management of HF so that patients with HF will be not delayed to receive appropriate treatment [ 25 ].…”
Section: Discussionmentioning
confidence: 99%
“…In their report, Siswanto, et al found that patients hospitalized for HF in Indonesia tend to have severe symptoms and lower LVEF [ 22 ]. It is a challenge for primary care providers and general practitioners in Indonesia to improve management of HF so that patients with HF will be not delayed to receive appropriate treatment [ 25 ].…”
Section: Discussionmentioning
confidence: 99%
“…Firstly, consumption of beta-blockers in Indonesia is expected to be considerably low, considering none of the beta-blockers is listed in the Bappenas top 50 pharmaceuticals list (Bappenas 2019 ). Secondly, cardioselective beta-blockers such as ATL and MPL are still considered not widely available in Indonesia; hence, they are less prescribed (Rizki and Siswanto 2014 ) and are not available over-the-counter. Additionally, studies have reported the use of other beta-blockers, e.g., bisoprolol and propranolol, by the Indonesian population (Rahmawati et al 2019 ; Sari 2020 ).…”
Section: Resultsmentioning
confidence: 99%